Trillium Therapeutics (NASDAQ: TRIL) presents data on TTI-621 (SIRPαFc) in blocking CD47 "do not eat" signal today. Key points ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE